Refuge Biotechnologies
company
About
Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Genetics,Health Care,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously – resulting in more potent and targeted treatments beyond a single target and function.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25M
Refuge Biotechnologies has raised a total of
$25M
in funding over 2 rounds. Their latest funding was raised on
May 2, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 2, 2018 | Series B | $25M | 2 |
3sbio
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Refuge Biotechnologies is funded by 2 investors.
3sbio
and Ocean Pine Healthcare Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
3sbio
|
Yes | Series B |
Ocean Pine Healthcare Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
